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a b s t r a c t
High-quality nucleic acids are critical for optimal PCR-based diagnostics and pathogen detection. Rapid sample processing time is important for the earliest administration of therapeutic and containment measures, especially in the case of biothreat agents. In this context, we compared the Fujiﬁlm QuickGene-Mini80 to
Qiagen's QIAamp Mini Puriﬁcation kits for extraction of DNA and RNA for potential use in austere settings.
Qiagen (QIAamp) column-based extraction is the currently recommended puriﬁcation platform by United
States Army Medical Research Institute for Infectious Diseases for both DNA and RNA extraction. However,
this sample processing system requires dedicated laboratory equipment including a centrifuge. In this
study, we investigated the QuickGene-Mini80, which does not require centrifugation, as a suitable platform
for nucleic acid extraction for use in resource-limited locations. Quality of the sample extraction was evaluated using pathogen-speciﬁc, real-time PCR assays for nucleic acids extracted from viable and γ-irradiated
Bacillus anthracis, Yersinia pestis, vaccinia virus, Venezuelan equine encephalitis virus, or B. anthracis spores
in buffer or human whole blood. QuickGene-Mini80 and QIAamp performed similarly for DNA extraction regardless of organism viability. It was noteworthy that γ-irradiation did not have a signiﬁcant impact on
real-time PCR for organism detection. Comparison with QIAamp showed a less than adequate performance
of the Fujiﬁlm instrument for RNA extraction. However, QuickGene-Mini80 remains a viable alternative to
QIAamp for DNA extraction for use in remote settings due to extraction quality, time efﬁciency, reduced
instrument requirements, and ease of use.
Published by Elsevier B.V.

1. Introduction
Biothreat agents, including Bacillus anthracis, Yersinia pestis, Variola
virus (vaccinia virus is a surrogate for Variola virus, the causative
agent of smallpox), and Venezuelan equine encephalitis virus (VEEV),
represent signiﬁcant public health risks due to high pathogenicity and
potential for aerosolization (Roy et al., 2010). Rapid and speciﬁc identiﬁcation of these pathogens is critical for initiation of appropriate containment and therapeutic measures as prognosis is directly impacted
by time to diagnosis. This is especially true for the potential of an intentional release of a biological agent. In this context, real-time PCR is currently implemented for the highly speciﬁc identiﬁcation of pathogens in
both clinical and environmental settings (Belgrader et al., 1998;
Christensen et al., 2006; Higgins et al., 1998; Makino et al., 2001; Ryu
et al., 2003; Shchelkunov et al., 2011; Skottman et al., 2007; Tomaso
et al., 2008).
Numerous factors inherent to clinical and environmental matrices
can inhibit downstream molecular diagnostic applications, such as
real-time PCR (Rossen et al., 1992; Wilson, 1997). The quality of the
⁎ Corresponding author at: USAMRIID, DSD, 1425 Porter Street, Fort Detrick, MD,
21702, USA. Tel.: +1 301 619 6352; fax: +1 301 619 2492.
E-mail address: timothy.minogue@us.army.mil (T.D. Minogue).

nucleic acids puriﬁed from a clinical or environmental sample is
critical for the optimal performance of these types of assays. This
puriﬁcation step is especially important for diagnostic pathogen detection where sensitivity is critical. Speciﬁc inhibitors of real-time
PCR diagnostics include hemoglobin (Akane et al., 1994) and polysaccharides (Monteiro et al., 1997) from blood as well as proteins from
food samples (Rossen et al., 1992) and humic and fulvic acids (Tsai
and Olson, 1992) from environmental samples. Beyond inhibitor
removal, release of target DNA/RNA is requisite for optimal molecular
assay kinetics. For bacteria and spores, efﬁcient lysis of the cell wall is
needed; however, these harsh lysing conditions must be tempered to
maintain the integrity of the extracted nucleic acids (Rantakokko-Jalava
and Jalava, 2002). Because of all these factors, most diagnostic applications of real-time PCR are accompanied by sample processing and
nucleic acid extraction.
Our lab has extensive experience using Qiagen's QIAamp Mini
Extraction Kits for DNA and RNA extraction of biothreat organisms.
These platforms perform well for extraction of clinical and environmental samples; however, the extraction protocols used require capital investment in equipment (ex. a centrifuge) as well as time for
processing (90 + min). While these kits are adequate for reference
laboratory use, this study sought to evaluate additional extraction
platforms that could yield similar results to the tested Qiagen kits
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but required less resources and potentially could reduce the time-toanswer. In this context, we evaluated Fujiﬁlm's QuickGene-Mini80
(QG-Mini80) platform as a possible solution in comparison to
QIAamp. To test the applicability of the QG-Mini80 for clinical biothreat
agent detection, nucleic acids were isolated from buffer and human
whole blood containing the serially diluted biothreat agents B. anthracis,
Y. pestis, vaccinia virus (VACV), and VEEV as well as B. anthracis spores.
Established real-time PCR-based assays were conducted to compare
puriﬁcation efﬁcacies as well as agent detectability from the extracted
nucleic acids.
2. Materials and methods
2.1. Bacterial and viral strains
Biothreat organisms maintained at United States Army Medical
Research Institute for Infectious Diseases (USAMRIID) or purchased
through the Critical Reagents Program (CRP, Frederick, MD), a reagents resource for biodefense research, were used for these studies.
Viable or γ-irradiated bacteria included B. anthracis Ames strain
vegetative cells and Y. pestis strain CO92 bacteria as well as
γ-irradiated B. anthracis Ames strain spores. Viruses included viable
VACV strain SALK 17633, γ-irradiated VACV strain Elstree/Lister,
and viable or γ-irradiated VEEV strain Trinidad donkey (IA/IB).
Organism was diluted into the appropriate matrix, either buffer
[Dulbecco's phosphate-buffered saline (PBS)] or human whole blood
(Bioreclamation, NY), to generate a stock, and this stock was then serially
diluted in the same matrix. B. anthracis Ames strain spores were diluted
into molecular grade water to prevent clumping, and concentrations
of viable spores were determined using sheep blood agar plates
(Remel, Lenexa, KS) incubated at 37 °C for 24 h. From this stock, serial dilutions of spores in water were made, and diluted spores were
sonicated using the Branson 2510 Ultrasonic Cleaner (Danbury, CT).
Previously quantiﬁed γ-irradiated spores were diluted into molecular grade water and sonicated, and serial dilutions into molecular
grade water were made.
2.2. Fujiﬁlm QuickGene-Mini80 platform
DNA from the diluted organisms or spores was isolated using the
QG-Mini80 DNA Tissue Kit. The manufacturer's instructions were
modiﬁed from the recommended protocol. Speciﬁcally, microcentrifuge
tubes containing 100 μl of sample (organism diluted in buffer or blood),
180 μl of lysis buffer (contains guanidine hydrochloride), and 20 μl of
proteinase K were mixed and incubated for 2 min at 55 °C. After this
incubation, 200 μl of ethanol (>99%) was added and mixed, and the
sample was applied to the column. Samples were washed three
times with wash buffer, and DNA was subsequently eluted in 100 μl of
elution buffer after a 90 sec incubation at room temperature. VEEV
RNA was extracted using the QG-Mini80 RNA Tissue Kit S II. Microcentrifuge tubes containing 70 μl of sample and 35 μl of buffer SRT were
combined. Thirty-ﬁve μl of ethanol (>99%) was added to the lysate,
mixed, and the sample was applied to the cartridge with three subsequent washes of buffer WRT. RNA was eluted in 100 μl of buffer CRT
after a 120 sec incubation at room temperature.
2.3. Qiagen QIAamp mini platform
DNA from the serially diluted organisms was manually isolated
using Qiagen's DNA mini platform with modiﬁcations to manufacturer's instructions. Speciﬁcally, microcentrifuge tubes containing
100 μl of sample, 80 μl of PBS, 200 μl of buffer AL (contains guanidine
hydrochloride), and 20 μl of proteinase K (17.8 mg/ml) were combined and incubated at 55 °C for 60 min. After this incubation,
210 μl of ethanol (>99%) was added. Samples were vortexed and
loaded onto a Qiagen spin column for centrifugation followed by

washing with buffers AW1 and AW2. After centrifugation to dry the
samples, DNA was eluted for 5 min at 70 °C using 100 μl of preheated
AE buffer (10 mM Tris-CL, 0.5 mM EDTA, pH 9.0). VEEV RNA from a
70 μl sample was extracted using Qiagen's QIAamp RNA Blood Mini
Kit according to the manufacturer's instructions.
2.4. Extraction efﬁciency measurement
In order to compare the extraction efﬁciencies for both platforms,
γ-irradiated B. anthracis vegetative cells were serially diluted 1:10 in
buffer from 1 × 10 7 to 1 × 10 4 colony forming units (CFU)/sample.
DNA was extracted from each sample in triplicate using either the
QIAamp DNA Mini kit or the QG-Mini80 DNA extraction kit. DNA
was quantiﬁed in triplicate, one sample per extraction for a total of
three replicates, using the Quant-iT PicoGreen dsDNA Reagent (Life
Technologies, Grand Isle, NY) according to the manufacturer's instructions. Statistical signiﬁcance in DNA extraction for each platform
was evaluated using a two-tail t-test at each sample dilution, assuming
equal variance.
2.5. Evaluation of the extracted material by agent-speciﬁc real-time PCR
All samples were evaluated for successful PCR ampliﬁcation via
real-time PCR using the R.A.P.I.D. thermocycler (Idaho Technology,
Inc., Salt Lake City, UT). Five μls of extracted nucleic acids were used
for each PCR reaction in a 20 μl reaction volume. For all of the
DNA-extracted organisms, the cycling conditions were 45 cycles of
95 °C for 0 s and 60 °C for 20 s. DNA extracted from B. anthracis
Ames was detected using a pX01-speciﬁc assay as previously described (Christensen et al., 2006). Y. pestis was detected using a PIMspeciﬁc assay as previously described (Christensen et al., 2006). VACV
primers targeting the polymerase were used at a ﬁnal concentration
of 0.5 mM for VACA25L-F151 (5′-CACCTCCACCAAAACCTAAAACTC)
and VACA25L-R231 (5′-AAAATgggCgTggATTgTTAAC). VACV probe
VACA25L-p193S-MGB (5′-AgACgTCCgATTCTAT) was used at 0.1 mM.
VEEV was detected using primers and probe targeting nsp2 (Parker
et al., 2010). Primers VEENSP2U (5′-CTTggCAAACCTCTggCAgC) and
VEENSP2L (5′-ATACCCACTCggTTCCAgCg) were used at a ﬁnal concentration of 0.9 mM, and probe VEENSP2P1A (5′-CTCTTCATgCAATgCC
CTTCTCCTgTCA) was used at a ﬁnal concentration of 0.06 mM. For
VEEV, the cycling conditions included a reverse transcriptase step of
50 °C for 15 min followed by a 5-min hold at 95 °C and 45 cycles of
95 °C for 0 s, 60 °C for 20 s using the SuperScript One-Step RT-PCR system (Life Technologies, Grand Island, NY) supplemented with 0.25 mM
BSA (Sigma-Aldrich, St. Louis, MO). All probes were labeled with FAM/
TAMRA. A real-time PCR sample was considered positive if the CT
value was b40 cycles. Negative results were noted if the number of
cycles were >40 or if no CT was observed. If any ﬂuorescence was observed for the no template control (NTC), the run was considered invalid.
For each analysis, we correlated real-time PCR CT values to the relative concentration of target, thus lower CT values correlated to an increase in target material. For each sample, three separate extractions
were conducted, and nucleic acids were quantiﬁed in triplicate with
one replicate coming from each extraction. The limit of detection
(LOD) or lowest amount of pathogen detectable was determined to
be the target organism concentration where all three extracted samples resulted in a positive result by real-time PCR.
3. Results
3.1. Platform ease of use, general characteristics, and extraction efﬁciencies
Initial evaluations focused on assessing general physical and ﬁscal
parameters as well as deﬁning any differences in extraction efﬁciency
between the QG-Mini80 and QIAamp using B. anthracis DNA extractions. For the QG-Mini80, up to eight samples could be extracted in
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buffer, QIAamp-puriﬁed material from blood showed better detectability than similar samples extracted using the QG-Mini80 for all agents
tested with the exception of VACV (Table 1). In this case, both platforms
yielded similar amounts of detectable VACV nucleic acid at 5 × 10 2 PFU/
ml; however, the CT value for the QIAamp extracted material was two
cycles lower than the QG-Mini80 extracted material. Furthermore, for
QIAamp's B. anthracis extraction, the detectable amount of DNA was
lower than the QG-Mini80 (50 and 100 CFU/ml, respectively) even
though two of three samples were positive at 50 CFU/ml for the
QG-Mini80-extracted material. Overall, the buffer and whole blood
data suggested better extraction efﬁciency for QIAamp puriﬁcation
compared to QG-Mini80.
3.3. DNA and RNA extraction from buffer and blood using viable pathogen
Fig. 1. Comparison of the amount of DNA recovered following serial dilution of
γ-irradiated B. anthracis in buffer. Triplicate serial dilutions of γ-irradiated B. anthracis
in buffer were puriﬁed with either the QG-Mini80 or the QIAamp DNA extraction kit.
The amount of DNA recovered was quantiﬁed (one sample per replicate) using the
Quant-iT PicoGreen dsDNA reagent. Statistical differences were measured using a t-test,
and * is a p value of b0.05.

approximately 15–20 min, compared to 108 min for 16 samples
using the QIAamp DNA extraction kit. Averaged times were based
on 48 B. anthracis DNA extractions. With regard to cost, both platforms are similarly priced per sample at USD $2.60 for the QGMini80 and $2.45 for the QIAamp DNA extraction kit. Overall, QIAamp
showed slightly better DNA recovery compared to QG-Mini80, with
statistically signiﬁcant differences at the 10 5 (p = 0.010) and the
10 6 (p = 0.04) CFU dilutions (Fig. 1). Beyond these variations in extraction efﬁciency, the principal difference noted from these data
was the time of extraction, with QIAamp taking an average of about
90 min longer than QG-Mini80 over the course of 48 samples. A comparison of the extraction efﬁciency for RNA was also performed using
the Quant-iT RiboGreen RNA Reagent and Kit (Life Technologies), but
the sensitivity of the RiboGreen kit was insufﬁcient to detect the
level of input RNA used in this study (data not shown). During
this evaluation and all subsequent analyses, we did not observe
cross-contamination between the samples with either platform; none
of the negative control reactions produced false positive results.
3.2. DNA and RNA extraction from buffer and blood using γ-irradiated
pathogen
The lowest amount of detectable pathogen was determined for
each γ-irradiated pathogen in buffer in order to optimize the
QG-Mini80 protocol and initially evaluate the quality of the extracted
nucleic acids from phylogenetically diverse biothreat agents (Table 1).
Buffer was used for this initial evaluation as it is a simple matrix and
contains limited inhibitors of PCR. Pathogen-speciﬁc real-time PCR
assays were used to assess extraction efﬁciencies, comparing the CT
values at different pathogen dilutions. Results from this comparison
varied and suggested better extraction efﬁciency with QIAamp. For example, the LOD for γ-irradiated Y. pestis was 50 CFU/ml for both platforms; however, CT values for the QIAamp-extracted DNA were one to
two cycles earlier. Positive samples were detected in two of the
three samples at the next lower dilution, 10 CFU/ml (Table 1). Similarly,
LODs for VACV (DNA) and VEEV (RNA) were lower for QIAamp [at
5 × 102 and 1 × 103 plaque forming units (PFU)/ml, respectively] than
QG-Mini80 (at 5 × 103 for both viruses) extracted material. Interestingly, the QG-Mini80 extracted material resulted in a lower amount of
detectable pathogen, 50 CFU/ml, for B. anthracis Ames vegetative cells
than the QIAamp at 100 CFU/ml (Table 1).
Deﬁning the clinical and diagnostic applicability of the QG-Mini80
platform was another central objective for this research. To test this
aspect, both QG-Mini80 and QIAamp were evaluated for extraction
efﬁciency using γ-irradiated organism spiked into human whole
blood as a representative clinical matrix. Similar to observations in

Evaluations with γ-irradiated biothreat agents suggested that the
QIAamp performed slightly better using the assessed real-time PCR
assays; however, this analysis did not address any impact the irradiation process may have had on the nucleic acid material before extraction. To assess if the QG-Mini80 and QIAamp protocols might perform
differently with non-irradiated material, we evaluated serially diluted
viable organisms in human whole blood (Table 2). Both platforms
yielded similar detectable amounts of nucleic acid for Y. pestis at
5 × 10 1 CFU/ml and VACV at 5 × 10 2 PFU/ml (Table 2). QG-Mini80
performed better than QIAamp at extracting viable B. anthracis from
whole blood, with detectable nucleic acid from 50 to 5 × 102 CFU/ml,
respectively. These results were signiﬁcantly contrasted by results
with viable VEEV. After several evaluations with two different viral stocks
and at titers of 1×106 PFU/ml, the QG-Mini80 was unable to consistently
extract detectable levels of VEEV RNA (Table 2 and data not shown).
3.4. Evaluation of extraction platforms for spore DNA isolation
The overall trend of lower sensitivities with QG-Mini80 suggested
this method may not be adequate for extracting some of the more recalcitrant biothreat samples. To test this hypothesis, we evaluated
DNA extraction on both platforms followed by real-time PCR for
γ-irradiated and viable B. anthracis spores serially diluted in water.
Table 1
Real-time PCR based (CT) evaluation of the QuickGene-Mini80 and QIAamp puriﬁcation
platforms of γ-irradiated biothreat agents diluted in buffer and whole blood.
Organism

CFU/
PFU/ml

CT values for QG-Mini80a

CT values for QIAampa

Buffer

Blood

Buffer

Blood

B. anthracis

1000
500
100
50
10
1000
500
100
50
10
50,000
10,000
5000
1000
500
50,000
10,000
5000
1000

30.21 ± 0.43
33.10 ± 0.39
35.15 ± 0.49
35.92 ± 0.91
37.43c
30.44 ± 0.34
31.97 ± 0.59
33.42 ± 0.81
34.95 ± 0.35
nd
31.20 ± 0.06
33.83 ± 0.45
35.48 ± 1.67
36.58c
37.49b
30.93 ± 0.97
31.71 ± 1.06
32.93 ± 0.26
32.39c

31.70 ± 0.23
31.66 ± 0.18
33.13 ± 0.47
33.68b
33.56c
30.41 ± 0.73
31.90 ± 0.33
34.16 ± 0.98
34.46 ± 0.96
36.06b
27.29 ± 0.86
30.35 ± 0.47
31.78 ± 0.47
34.64 ± 0.22
34.92 ± 1.40
32.42 ± 0.16
32.35 ± 0.83
nd
nd

30.73 ± 0.55
31.81 ± 0.45
34.79 ± 0.44
34.51b
37.32c
28.97 ± 0.43
29.94 ± 0.33
32.59 ± 0.07
34.02 ± 0.50
36.50b
29.93 ± 0.18
32.67 ± 0.30
33.25 ± 0.39
35.72 ± 1.31
35.87 ± 0.62
29.14 ± 0.17
30.82 ± 1.81
31.97 ± 0.07
32.91 ± 0.18

30.17 ± 0.32
30.73 ± 0.46
33.08 ± 0.20
33.15 ± 0.75
33.40b
29.13 ± 0.23
30.35 ± 0.39
32.94 ± 0.53
33.78 ± 0.92
35.74 ± 0.78
25.37 ± 2.12
28.60 ± 0.53
29.22 ± 0.22
32.82 ± 0.51
32.85 ± 0.41
28.16 ± 0.22
29.52 ± 0.69
31.17 ± 0.53
31.56 ± 0.63

Y. pestis

VACV

VEEV

± is the standard deviation of one real-time PCR assay from three replicates; nd = not
detected.
a
A positive sample had a CT value b40 cycles, and a negative sample had a CT value
of >40 cycles.
b
Two of three replicates gave valid results.
c
One of three replicates gave valid results.
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Table 2
Real-time PCR based (CT) evaluation of the QuickGene-Mini80 and QIAamp puriﬁcation
platforms of viable biothreat agents in whole blood.
Organism

CFU/PFU/ml

CT values for QG-Mini80a

CT values for QIAampa

B. anthracis

1000
500
100
50
1000
500
100
50
10,000
5000
1000
500
50,000
10,000
5000
1000

30.09 ± 0.15
32.08 ± 0.27
33.41 ± 0.78b
33.67 ± 0.79
30.17 ± 0.45
31.72 ± 0.19
35.30 ± 1.75
35.54 ± 0.87
25.79 ± 1.13
27.33 ± 0.29
29.86 ± 0.83
30.85 ± 0.19
nd
nd
35.37b
nd

31.18 ± 0.78
31.37 ± 0.07
nd
nd
30.00 ± 0.20
31.56 ± 0.50
34.01 ± 0.29
36.46 ± 0.60
25.30 ± 0.87
25.98 ± 0.94
28.27 ± 0.50
29.65 ± 1.68
27.94 ± 0.84
30.22 ± 1.21
29.60 ± 3.71
32.97 ± 1.50

Y. pestis

VACV

VEEV

± is the standard deviation of one real-time PCR assay from three replicates; nd = not
detected.
a
A positive sample had a CT value b40 cycles, and a negative sample had a CT value
of >40 cycles.
b
Two of three replicates gave valid results.

The lowest amount of detectable spore material extracted with QIAamp
was 5 × 10 2 CFU/ml compared to 5 × 10 3 CFU/ml with the QG-Mini80,
supporting this hypothesis (Table 3). Data with viable B. anthracis
Ames spores showed a similar trend, although with less of a disparity
between the detectable amounts of input spores.
4. Discussion
In the event of an infection with an unknown agent, rapid pathogen detection is critical for containment and efﬁcacious treatment.
For diagnostics and real-time PCR detection of etiologic agents,
our current standard extraction methods are Qiagen QIAamp DNA
Mini Kit and QIAamp Blood RNA Mini Kit. These platforms utilize
chaotropic lysis and silica-gel based nucleic acid binding using centrifugation for sample binding, washing, and nucleic acid elution. While
this method yields excellent nucleic acids, the process is time consuming (approximately 2 h from sample to extracted material) and
requires equipment, such as a centrifuge, that limits the use of these
platforms in resource-limited settings. Fujiﬁlm's QG-Mini80 platform
for DNA and RNA extraction is a potential alternative to QIAamp for
nucleic acid extraction. Rose et al. recently described the QG-Mini80,
along with the Instagene Only (Bio-Rad, Hercules, CA), as the easiest
to use among 8 different methods they evaluated for Bacillus atrophaeus

Table 3
Real-time PCR based (CT) evaluation of the QuickGene-Mini80 and QIAamp puriﬁcation
platforms for B. anthracis spores in water.
Organism

CFU/ml

CT values for QG-Mini80a

CT values for QIAampa

B. anthracis
(γ-irradiated)

10,000
5000
1000
500
10,000
5000
1000
500

32.78 ± 0.32
34.93 ± 2.04
34.81b
nd
34.32 ± 1.37
34.85b
37.08c
37.72c

30.41 ± 1.50
31.25 ± 0.57
34.71 ± 2.39
34.69 ± 0.84
30.85 ± 0.57
32.57 ± 1.20
34.20c
35.65c

B. anthracis
(viable)

± is the standard deviation of one real-time PCR assay from three replicates; nd = not
detected.
a
A positive sample had a CT value b40 cycles, and a negative sample had a CT value
of >40 cycles.
b
Two of three replicates gave valid results.
c
One of three replicates gave valid results.

spore DNA extraction (Rose et al., 2011). This technology utilizes similar
chaotropic lysis and a thin, silica-based membrane for nucleic acid
extraction but, instead of centrifugation, uses positive pressure for
sample application, membrane washing, and elution. Additionally,
the QG-Mini80 has short sample processing time (approximately
15–20 min for eight samples), a small footprint, greater ease of use,
and minimal power requirements. The objective of this research was
to assess the QG-Mini80 platform for the quality of nucleic acid extraction within a clinical context for use in austere settings.
Comparison of the extraction efﬁciencies suggested a trend of better yields for the QIAamp DNA Mini Kit compared to QG-Mini80, especially at lower target DNA concentrations. This could be the result
of several differences between the platforms, including membrane
size and different lysing/binding/washing chemistries. The QG-Mini80
ﬁlter is approximately 80 μm in thickness compared to the typical silica
membrane of up to 1000 μm. While Fujiﬁlm advertises equivalent
surface area due to the porosity of its membrane, the reduced DNA
recovery for the QG-Mini80 suggests either a reduced binding potential compared to the canonical spun glass ﬁber columns of QIAamp or
a less efﬁcient processing, i.e. lysis of the sample or removal of PCR
inhibitors. Regardless of the speciﬁc reasons for the reduced DNA recovery, this did not directly correlate to less effective detection of the
extracted material. This is demonstrated with viable B. anthracis in
a clinical matrix where overall sensitivity in downstream PCR
reactions was better with QG-Mini80 extractions compared to
QIAamp. It is possible that a more comprehensive study comparing
QG-Mini80 and QIAamp might show more difference or similarity
in the detectability of extracted materials; however, the presented
data show the QG-Mini80 is suitable for use in remote environments
in the clinical arena for DNA-based organisms. In general, QG-Mini80
and QIAamp resulted in roughly comparable sensitivities for the
extracted material with cross-platform differences being only 1-log,
and more often a 1/2‐log, in disparity for DNA-based organisms.
Similar results were observed by Rose et al., who compared 8 different DNA extraction platforms for extraction efﬁciency using powder, liquid, solid, and swabs as the matrix type. While QIAamp was
not evaluated in this study, the QG-Mini80 performed acceptably
(ranked 6/8 of platforms across the sample types) (Rose et al.,
2011). The QG-Mini80 also performed acceptably for extracting detectable nucleic acid within clinically relevant ranges in this study.
This statement is contrasted by data presented here; RNA-based and
spore-forming organisms require more detailed optimization and investigation before recommended ﬁeld use.
Prior to this research, it was unclear whether the irradiation process would detrimentally impact real-time PCR which target smaller
amplicons than previous studies have evaluated (Lim et al., 2006;
Trampuz et al., 2006). Use of γ-irradiated biothreat agents in biosafety level 2 as a surrogate for viable agent is highly preferential
given the safety precautions required for working with biosafety
level 3 + organisms and the corollary ﬁscal impact. Comparing
data from γ-irradiated and viable agent extractions suggest marginal
impact on extraction efﬁcacy and/or downstream detection. One counterpoint to this statement speciﬁc to the QG-Mini80 is the extraction of
viable VEEV RNA. Real-time PCR results with γ-irradiated VEEV
showed better extraction for QIAamp; however, while results of
the QG-Mini80 were consistent, there were also dramatically
lower amounts of detectable RNA extracted for γ-irradiated compared to QIAamp and non-existent amounts for viable agent. Lack
of sufﬁcient extraction results with viable VEEV cannot be attributed to major sample differences as QIAamp extractions were comparable, viable or γ-irradiated. This may be a speciﬁc result to the
QG-Mini80 chemistry as this phenomenon has not been observed
previously in our lab. Reasons for poor and inconsistent performance
with viable VEEV could be attributed to a variety of factors, but
more research with the QG-Mini80 is required to draw any proper
conclusions.
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The QG-Mini80's ﬂexibility, portability, ease of use, and time-toanswer are all considerations that make this instrument an attractive
alternative to column-based manual extractions. The QG-Mini80
has several advantages over its QIAamp counterpart currently recommended to ﬁeld users. In 15–20 min, eight samples are ready for
PCR, an hour and a half faster than Qiagen. While both procedures utilize afﬁnity chromatography for nucleic acid capture, Qiagen columns
are centrifuged and transferred during each wash, dry, and elution
step whereas the QG-Mini80 columns are racked and remain stationary, allowing minimal sample handling and no centrifugation. This
would be ideal for extraction of DNA-based pathogens where minimal
manipulation and aerosol generation are highly desired. In addition,
the QG-Mini80 is highly transportable with its compact size of 3 kg
and measurements of 22 × 28 in. The principle caveat is the comparative performance. RNA-based puriﬁcation was unacceptable, however,
results with DNA are adequate and within relevant target organism
ranges for diagnostic applications.
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